Galapagos NV
GLPG
#5036
Rank
ยฃ1.41 B
Marketcap
ยฃ21.01
Share price
0.00%
Change (1 day)
4.01%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): -ยฃ0.28

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -ยฃ0.31. In 2025 the company made an earnings per share (EPS) of ยฃ4.34 an increase over its 2024 EPS that were of ยฃ0.88.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-ยฃ0.28-106.48%
2025ยฃ4.34390.86%
2024ยฃ0.88-67.16%
2023ยฃ2.69-199.64%
2022-ยฃ2.7099.03%
2021-ยฃ1.36-68.98%
2020-ยฃ4.37-298.06%
2019ยฃ2.21-554.64%
2018-ยฃ0.49-77.18%
2017-ยฃ2.13-326.21%
2016ยฃ0.94-134.19%
2015-ยฃ2.75-371.34%
2014ยฃ1.01-445.98%
2013-ยฃ0.2932.88%
2012-ยฃ0.22-82.07%
2011-ยฃ1.23-817.9%
2010ยฃ0.1712.73%
2009ยฃ0.15-120.79%
2008-ยฃ0.73-37.67%
2007-ยฃ1.1739.64%
2006-ยฃ0.8428.17%
2005-ยฃ0.666.25%
2004-ยฃ0.62

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ6.62-2,244.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ2.73-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ1.56-604.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.94-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ2.70-973.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ5.27-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ2.94-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-ยฃ0.46 49.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.04-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel